Interviews

As in the previous years, EANpages asked EAN committee members, panel chairs, and invited speakers  which session one should not miss at the upcoming congress in Lisbon 2018. Please find their answers below!

David B. Vodušek (DBV): When looking back at your long and varied career, can you tell us what was crucial for you to choose neurology as your specialty, and headache as your primary research field of interest?  Jes Olesen (JO): Already as a medical student, I was interested in neurology. I thought at that time – and I still think so today – that the brain is by far the most interesting organ in a human being.

David B Vodušek (DBV): In light of your long-standing experience in the world of neurology world-wide, what would your “diagnosis” be concerning its “state of art”? William Carroll (WC): What a good question to begin with. I would say my “diagnosis” is healthy and its prognosis is one of cautious optimism mixed with exciting opportunities and challenges.

David B. Vodušek (DBV): The Scientific Panel for Health – SPH is an official and unique panel of the EC within H2020. Can you introduce the SPH to the readers of EAN and explain its tasks? Karin Sipido (KS): The European Commission’s Scientific Panel for Health is a science-led expert group based on the provisions of the Horizon2020 Specific Programme.

Prof. Gunhild Waldemar (GW): Geriatric medicine has become very important in our fast ageing European population.I invite you to introduce the European Union Geriatric Medicine Society – EUGMS of which you are the president to the EANpages readership. Can you please explain to the readers of the EAN Pages what the EUGMS stands for and what its objectives and aims are? Prof. Stefania Maggi (SM): The European Union Geriatric Medicine Society, EUGMS, is the collaborating and co-ordinating organisation of the national geriatric medical societies of the European Union member states, but also includes Norway, Switzerland and Iceland. The EUGMS’ mission is to develop geriatric medicine in all member states as a recognised independent medical specialty, contributing to the care of all older people with age related diseases.

David B. Vodušek (DBV): Can you tell us about your training and how you ended up looking after neurological patients with uro-neurological symptoms? David B. Vodušek (DBV): Can you tell us about your training and how you ended up looking after neurological patients with uro-neurological symptoms? Clare J Fowler (CJF): My early training included neurology at a junior level, but when it came to choosing a career path I was advised to pursue clinical neurophysiology, on the grounds that it could be a 'suitable' job for a woman with children. Furthermore, there was a UK shortage of consultant neurophysiologists.

the understanding or treatment of MS. David B. Vodušek (DBV): Can you tell us about your training and how you ended up looking after neurological patients with MS and pursuing research in MS? Per Soelberg Sorensen (PSS): When I was a young doctor, I was fascinated by neurology because of the way the neurologist would deduct where the lesion in the nervous system was located based on the history and objective examination. This was before the appearance of scanners.

eter Van den Bergh (PVdB): Peripheral neuropathies are common neurological disorders. In the annual EAN congresses, they are an important topic which the Scientific Panel Neuropathies strives to integrate in the scientific and in the educational Program. I would like to introduce the Peripheral Nerve Society (PNS) of which you are the president to the EANpages readership. Can you please explain what the PNS stands for and what its objectives and aims are to the readers of the EANpages? Mary Reilly (MR): The Peripheral Nerve Society (PNS) is an international organisation of physicians and scientists working together to develop and provide the best treatments for people who have peripheral nerve diseases.

Franz Fazekas (FF): Dear Prof. Uitdehaag, the 3rd Congress of the EAN will bring 6000 neurologists to Amsterdam. How do you and the Dutch neurological community feel about hosting Europe’s major neurological scientific event of the year? Bernard Uitdehaag (BU): We are excited that the EAN congress will be held in Amsterdam in June this year. As a president of the Netherlands Society of Neurology, I was involved in releasing a bid for the organization of an EAN congress a couple of years ago.

Franz Fazekas (FF): Dear Prof. Boon, as Chair of the Programme Committee of the 3rd Congress of the EAN, can you briefly illustrate the overarching theme and structure of the programme that you and your colleagues have put together? Paul Boon (PB): The overarching theme chosen for the Amsterdam congress is "Outcome measures in neurology". There are many reasons why this theme was chos

As in the previous year, EANpages asked EAN committee members, panel chairs, and invited speakers  which session one should not miss at the upcoming congress in Amsterdam 2017. Please find their answers below! Mark Braschinsky , speaker at the Case… Continue Reading

As in the previous years, EANpages asked EAN committee members, panel chairs, and invited speakers  which session one should not miss at the upcoming congress in Lisbon 2018. Please find their answers below!

As in the previous years, EANpages asked EAN committee members, panel chairs, and invited speakers  which session one should not miss at the upcoming congress in Lisbon 2018. Please find their answers below!

Marianne de Visser (MdV): Neuromuscular diseases are an important topic on our annual congresses, both in the Scientific and in the Educational Program. Therefore we would like to introduce the World Muscle Society of which you are the founding father to the EANpages readership. Can you please briefly illustrate the WMS and its goals to the readers of the EANpages? Victor Dubowitz (VD): In March 1995 I met up with Giovanni Nigro and Luciano Merlini in Bologna to discuss the formation of a new international society dedicated to neuromuscular diseases.